Giovanni Cagnotto

Medicin och livsvetenskap

1. Rheumatoid Arthritis 100%
2. Rheumatology 62%
3. Antisynthetase syndrome 55%
4. Tenosynovitis 44%
5. Tumor Necrosis Factor Inhibitors 38%
6. Abatacept 34%
7. Synovitis 29%
8. Multicenter Studies 27%
9. Observational Studies 27%
10. Anti-Citrullinated Protein Antibodies 24%
11. Rheumatic Diseases 24%
12. Interstitial Lung Diseases 21%
13. Coronavirus 20%
14. Antibody Specificity 19%
15. Psoriatic Arthritis 19%
16. Gout 19%
17. Juvenile Arthritis 19%
18. Arthritis 18%
19. Validation Studies 17%
20. Amino Acyl-tRNA Synthetases 17%
21. Antirheumatic Agents 17%
22. Joints 17%
23. Uric Acid 16%
24. Autoimmune Diseases 15%
25. Systemic Lupus Erythematosus 15%
26. Tumor Necrosis Factor-alpha 14%
27. Anti-Idiotypic Antibodies 13%
28. Research Personnel 13%
29. Atherosclerosis 12%
30. Vaccination 12%
31. Confidence Intervals 12%
32. Clinical Trials 12%
33. Health 12%
34. Survival 12%
35. Logistic Models 11%
36. Placebos 11%
37. Certolizumab Pegol 10%
38. Databases 9%
39. ametantrone 9%
40. tocilizumab 9%
41. Rheumatologists 9%
42. Odds Ratio 9%
43. Therapeutics 8%
44. Kidney 8%
45. Lupus Nephritis 7%
46. Myositis 6%
47. Pharmaceutical Preparations 6%
48. Tendons 6%
49. Sensitivity and Specificity 6%
50. Wrist Joint 6%